Streamex and Monetary Metals partner on tokenized gold yield product

LOS ANGELES/SCOTTSDALE - BioSig Technologies, Inc. (NASDAQ:BSGM), a small-cap technology company with a market capitalization of $74.28 million, and Monetary Metals announced Monday a strategic partnership to develop tokenized gold products targeting up to 4% annual yield for investors. According to InvestingPro data, BSGM has shown remarkable momentum with a 195.97% return year-to-date.

The exclusive three-year agreement gives Streamex, a wholly owned subsidiary of BioSig, rights to tokenize Monetary Metals’ yield-bearing gold products while providing access to the company’s precious metals leasing and bond programs. Despite the ambitious partnership, InvestingPro analysis indicates the company faces financial challenges, with a weak overall financial health score and current liabilities exceeding liquid assets.

Under the partnership terms, Streamex will fund at least 10% of eligible Monetary Metals gold leases and receive a revenue share tied to leasing volumes on the platform. The companies aim to combine physical gold holdings with blockchain technology to create institutional-grade investment products.

"By earning yield on our gold holdings and creating tokenized yield products, we are building the foundation for scalable, institutional-grade instruments that can support billions of dollars in investment," said Henry McPhie, CEO of BioSig and Co-Founder of Streamex.

The collaboration will allow investors to potentially earn returns on tokenized gold bullion products while Streamex will also generate yield on its own gold treasury holdings.

Keith Weiner, Founder and CEO of Monetary Metals, stated, "Our vision has been to unlock gold’s natural utility by using it to finance real-world businesses and generate a yield."

Streamex focuses on real-world asset tokenization specifically for gold and commodities markets, while Monetary Metals specializes in gold and silver denominated financial products.

The announcement was made in a press release statement issued by both companies. While BSGM’s stock has demonstrated significant volatility with a 462.07% surge over the past six months, investors should note that InvestingPro maintains additional crucial insights about the company’s financial outlook, with 12 more exclusive ProTips available to subscribers.

In other recent news, BioSig Technologies, Inc. has completed a significant financial maneuver by raising approximately $15 million through an underwritten public offering. The company sold 3,852,149 shares of common stock at $3.90 per share, with the intention of using the net proceeds to purchase gold bullion as part of its investment strategy and for general corporate purposes. This public offering follows BioSig’s recent merger with Streamex Exchange Corporation. Additionally, BioSig Technologies’ shareholders have approved an amendment to the company’s certificate of incorporation to increase the number of authorized shares from 200,000,000 to 500,000,000. This amendment was filed with the Secretary of State of Delaware and became effective immediately. These developments reflect BioSig’s strategic initiatives to enhance its financial position and expand its investment capabilities.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.